A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01652898
Recruitment Status : Completed
First Posted : July 30, 2012
Last Update Posted : September 5, 2012
Information provided by (Responsible Party):
AOP Orphan Pharmaceuticals AG

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2012
  Study Completion Date : August 2012